---
figid: PMC2360544__95-6603223f2
figlink: /pmc/articles/PMC2360544/figure/fig2/
number: F2
caption: 'Novel therapeutic targets and proposed mechanisms of androgen resistance
  (text in red) in hormone refractory prostate cancer. (1) Hypersensitive Pathway:
  AR amplification, increased AR expression or alterations in corepressor/coactivator
  function. (2) Versatile receptor: mutations in the ligand-binding domain of the
  AR permitting nonandrogenic ligand binding. (3) Alternative routes: utilisation
  of AR machinery by alternative pathways, that is, PI3K/Akt. (4) Bypass pathways:
  bypassing of the AR and its cellular machinery entirely, that is, upregulation of
  the antiapoptotic protein Bcl-2. Therapeutic targets include: the adrenal steroid
  synthesis pathway, AR signalling, growth factor receptors (GFR), PTEN (phosphatase
  and tensin homolog) and PI3K (phosphatidylinositide 3-OH kinase) signalling, angiogenesis
  and apoptosis. HSP90 denotes heat shock protein 90; PIP2 phosphatidylinositol-4,5-
  bisphosphate; PIP3 phosphatidylinositol-3,4,5- triphosphate; Akt protein kinase
  B; mTOR mammalian target of rapamycin; oncogenes Ras, Raf, Mek, Erk; Bcl-2 antiapoptotic
  protein; APAF1 apoptotic peptidase activating factor 1; IAP inhibitor of apoptosis
  family (of which survivin is a member). Solid lines indicate promotion. Broken lines
  indicate inhibition.'
pmcid: PMC2360544
papertitle: Improving the outcome of patients with castration-resistant prostate cancer
  through rational drug development.
reftext: G Attard, et al. Br J Cancer. 2006 Oct 9;95(7):767-774.
pmc_ranked_result_index: '14489'
pathway_score: 0.7993891
filename: 95-6603223f2.jpg
figtitle: Novel therapeutic targets and proposed mechanisms of androgen resistance
  (text in red) in hormone refractory prostate cancer
year: '2006'
organisms: Homo sapiens
ndex: a454e98e-df2a-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2360544__95-6603223f2.html
  '@type': Dataset
  description: 'Novel therapeutic targets and proposed mechanisms of androgen resistance
    (text in red) in hormone refractory prostate cancer. (1) Hypersensitive Pathway:
    AR amplification, increased AR expression or alterations in corepressor/coactivator
    function. (2) Versatile receptor: mutations in the ligand-binding domain of the
    AR permitting nonandrogenic ligand binding. (3) Alternative routes: utilisation
    of AR machinery by alternative pathways, that is, PI3K/Akt. (4) Bypass pathways:
    bypassing of the AR and its cellular machinery entirely, that is, upregulation
    of the antiapoptotic protein Bcl-2. Therapeutic targets include: the adrenal steroid
    synthesis pathway, AR signalling, growth factor receptors (GFR), PTEN (phosphatase
    and tensin homolog) and PI3K (phosphatidylinositide 3-OH kinase) signalling, angiogenesis
    and apoptosis. HSP90 denotes heat shock protein 90; PIP2 phosphatidylinositol-4,5-
    bisphosphate; PIP3 phosphatidylinositol-3,4,5- triphosphate; Akt protein kinase
    B; mTOR mammalian target of rapamycin; oncogenes Ras, Raf, Mek, Erk; Bcl-2 antiapoptotic
    protein; APAF1 apoptotic peptidase activating factor 1; IAP inhibitor of apoptosis
    family (of which survivin is a member). Solid lines indicate promotion. Broken
    lines indicate inhibition.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CB
  - HRAS
  - TMPRSS2
  - MAPK1
  - CYTL1
  - ETS2
  - AKT1
  - ARAF
  - PIK3CA
  - PIK3CG
  - MAPK3
  - NRAS
  - PIK3CD
  - ADAR
  - AKT3
  - AR
  - PIK3R4
  - KRAS
  - MAP2K1
  - RAF1
  - BRAF
  - MAP2K2
  - ETS1
  - MTOR
  - AKT2
  - PIK3R5
  - PIK3R3
  - PIK3R6
  - androgens
  - Testosterone
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: (PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: TMPRSS2/ETS
  symbol: TMPRSS2
  source: hgnc_symbol
  hgnc_symbol: TMPRSS2
  entrez: '7113'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: (C17,20-yase)
  symbol: C17
  source: hgnc_alias_symbol
  hgnc_symbol: CYTL1
  entrez: '54360'
- word: TMPRSS2/ETS
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS2
  entrez: '2114'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: (PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: (PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: (PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: adAR
  symbol: ADAR
  source: hgnc_symbol
  hgnc_symbol: ADAR
  entrez: '103'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: (PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: (MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: (MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: TMPRSS2/ETS
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS1
  entrez: '2113'
- word: (MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: (PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: (PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: (PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
chemicals:
- word: androgens
  source: MESH
  identifier: D000728
- word: Testosterone
  source: MESH
  identifier: D013739
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC2360544__F2
redirect_from: /figures/PMC2360544__F2
figtype: Figure
---
